
    
      Patients with symptomatic superficial leg thrombosis will be randomized into two arms, a)
      rivaroxaban 10mg 1 tablet daily for 45 days or b) placebo to determine if rivaroxaban (10 mg
      once daily) is an effective and safe treatment for superficial vein thrombosis.
    
  